Aquestive Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Boyd Peter E. | Chief People Officer | Award / Grant | 20,000 | — | — | 288,323 | Dec 4, 2025 |
| Cioffi Melina | SVP, Regulatory Affairs | Tax Withholding | 2,083 | $5.93 | $12,352 | 200,178 | Dec 2, 2025 |
| Davis Matthew W. | Chief Development Officer | Award / Grant | 50,000 | — | — | 50,000 | Nov 10, 2025 |
| Jung Cassie | Chief Operating Officer | Option Exercise | 25,000 | $3.10 | $77,500 | 308,346 | Oct 15, 2025 |
| Kraus Carl N | Chief Medical Officer | Sale | 20,272 | $7.00 | $141,904 | 282,475 | Oct 15, 2025 |
| Boyd Peter E. | See Remarks | Sale | 10,000 | $7.00 | $70,000 | 268,323 | Oct 15, 2025 |
| Barber Daniel | President and CEO | Sale | 91,343 | $6.03 | $550,798 | 923,430 | Sep 26, 2025 |
| Boyd Peter E. | See Remarks | Sale | 10,000 | $6.30 | $63,000 | 278,323 | Sep 26, 2025 |
| Barber Daniel | President and CEO | Sale | 400 | $6.00 | $2,400 | 1,014,773 | Sep 19, 2025 |
| Boyd Peter E. | See Remarks | Sale | 15,000 | $5.30 | $79,500 | 288,323 | Sep 5, 2025 |
| Jung Cassie | Chief Operating Officer | Option Exercise | 25,000 | $0.71 | $17,750 | 345,526 | Sep 4, 2025 |
| Korczynski Sherry | Chief Commercial Officer | Award / Grant | 25,000 | — | — | 181,858 | Aug 14, 2025 |
| Kraus Carl N | Chief Medical Officer | Tax Withholding | 10,819 | $3.90 | $42,194 | 302,747 | Aug 9, 2025 |
| Korczynski Sherry | SVP Sales and Marketing | Tax Withholding | 2,714 | $3.54 | $9,608 | 156,858 | Jun 9, 2025 |
| Cioffi Melina | SVP, Regulatory Affairs | Award / Grant | 20,000 | — | — | 202,261 | May 15, 2025 |
| Wargacki Stephen | Chief Science Officer | Tax Withholding | 12,859 | $2.65 | $34,076 | 363,555 | Mar 7, 2025 |
| Jung Cassie | Chief Operating Officer | Tax Withholding | 2,182 | $2.54 | $5,542 | 295,526 | Mar 7, 2025 |
| TOTH A ERNEST JR | Chief Financial Officer | Tax Withholding | 10,193 | $2.65 | $27,011 | 348,102 | Mar 7, 2025 |
| Kraus Carl N | Chief Medical Officer | Award / Grant | 70,000 | — | — | 321,681 | Mar 7, 2025 |
| Korczynski Sherry | SVP Sales and Marketing | Tax Withholding | 5,428 | $2.65 | $14,384 | 159,572 | Mar 7, 2025 |
| BRAENDER LORI J | Chief Legal Officer | Tax Withholding | 9,592 | $2.65 | $25,419 | 413,639 | Mar 7, 2025 |
| Boyd Peter E. | See Remark | Tax Withholding | 7,681 | $2.65 | $20,355 | 303,323 | Mar 7, 2025 |
| Barber Daniel | President and CEO | Award / Grant | 272,000 | — | — | 1,098,478 | Mar 7, 2025 |
| BRATTON DOUGLAS K | — | Gift | 40,000 | — | — | 199,841 | Dec 2, 2024 |
| Jung Cassie | Chief Operating Officer | Sale | 44 | $4.87 | $214 | — | Nov 26, 2024 |
| Kraus Carl N | Chief Medical Officer | Tax Withholding | 10,819 | $3.43 | $37,109 | 251,681 | Aug 9, 2024 |
| Korczynski Sherry | SVP Sales and Marketing | Award / Grant | 25,000 | — | — | 25,000 | Jun 7, 2024 |
| Wargacki Stephen | Chief Science Officer | Award / Grant | 10,000 | — | — | 267,963 | May 10, 2024 |
| Schobel Alexander Mark | Chief Innovation/Tech Officer | Sale | 50,000 | $6.00 | $300,000 | 984,476 | Mar 15, 2024 |
| Jung Cassie | SVP, Operations | Tax Withholding | 8,300 | $4.88 | $40,504 | 238,886 | Mar 10, 2024 |
| Barber Daniel | President and CEO | Tax Withholding | 37,938 | $4.88 | $185,137 | 845,364 | Mar 9, 2024 |
| Boyd Peter E. | See Remark | Tax Withholding | 8,370 | $4.88 | $40,846 | 237,628 | Mar 9, 2024 |
| BRAENDER LORI J | SVP, General Counsel | Tax Withholding | 10,530 | $4.88 | $51,386 | 313,231 | Mar 9, 2024 |
| TOTH A ERNEST JR | SVP, Chief Financial Officer | Tax Withholding | 11,705 | $4.88 | $57,120 | 248,295 | Mar 9, 2024 |
| Wargacki Stephen | SVP, Research & Development | Tax Withholding | 1,687 | $4.88 | $8,233 | 257,963 | Mar 9, 2024 |
| Schobel Alexander Mark | Chief Innovation/Tech Officer | Tax Withholding | 9,645 | $4.88 | $47,068 | 980,726 | Mar 9, 2024 |
| Wargacki Stephen | Chief Science Officer | Tax Withholding | 19,505 | $4.88 | $95,184 | 261,414 | Mar 9, 2024 |
| Barber Daniel | President and CEO | Tax Withholding | 56,824 | $4.88 | $277,301 | 826,478 | Mar 9, 2024 |
| Jung Cassie | SVP, Operations | Tax Withholding | 14,120 | $4.88 | $68,906 | 233,066 | Mar 9, 2024 |
| Schobel Alexander Mark | Chief Innovation/Tech Officer | Tax Withholding | 5,895 | $4.88 | $28,768 | 1,034,476 | Mar 8, 2024 |
| BRAENDER LORI J | SVP, General Counsel | Award / Grant | 135,000 | — | — | 323,761 | Mar 7, 2024 |
| TOTH A ERNEST JR | SVP, Chief Financial Officer | Award / Grant | 120,000 | — | — | 260,000 | Mar 7, 2024 |
| Schobel Alexander Mark | Chief Innovation/Tech Officer | Award / Grant | 82,500 | — | — | 1,065,371 | Mar 7, 2024 |
| Kraus Carl N | Chief Medical Officer | Award / Grant | 112,500 | — | — | 262,500 | Mar 7, 2024 |
| Barber Daniel | President and CEO | Award / Grant | 242,600 | — | — | 883,302 | Mar 7, 2024 |
| Boyd Peter E. | See Remark | Award / Grant | 86,250 | — | — | 245,998 | Mar 7, 2024 |
| Kraus Carl N | Chief Medical Officer | Award / Grant | 150,000 | — | — | 150,000 | Aug 9, 2023 |
| Jung Cassie | SVP, Operations | Award / Grant | 101,250 | — | — | 247,186 | Mar 10, 2023 |
| Wargacki Stephen | SVP, Research & Development | Award / Grant | 112,500 | — | — | 270,919 | Mar 10, 2023 |
| Boyd Peter E. | See Remark | Award / Grant | 100,000 | — | — | 159,532 | Mar 9, 2023 |